Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (81-90 of 538) with videos related to

Pageof 54
Sort By:
Biochemical Pharmacology|September 29, 2000
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosisB P Neve, J C Fruchart, B Staels
La Revue De Medecine Interne|January 1, 1994
[Vitamin E, antioxidants and atherosclerosis]J M Lecerf, G Luc, J C Fruchart
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 22, 2005
Therapeutical effects of PPAR agonists assessed by biomarker modulationG Chinetti-Gbaguidi, J-C Fruchart, B Staels
The American Journal of Cardiology|April 29, 1998
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus GroupJ C Fruchart, H B Brewer, E Leitersdorf
European Journal of Clinical Investigation|February 18, 1998
Fat ingestion is associated with increased levels of apoC-III- and apoE-B-containing lipoprotein particles in humansJ Dallongeville, E Baugé, P Lebel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 1979
[Lipoprotein electrophoresis on acrylamide-agarose plates, with discontinuous acrylamide gradient]S Moulin, J C Fruchart, P Dewailly, et al.
Biochemical and Biophysical Research Communications|January 15, 1987
Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesR Barbaras, P Puchois, J C Fruchart, et al.
Atherosclerosis|July 1, 1996
Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPARJ Auwerx, K Schoonjans, J C Fruchart, et al.
Diabete & Metabolisme|September 1, 1977
[Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)]J Jaillard, G Sezille, P Dewailly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Lack of triglyceride-lowering properties of fish oil in apolipoprotein e-deficient miceG Asset, E Baugé, J C Fruchart, et al.
Pageof 54

Showing results (81-90 of 538) with videos related to

Sort By:
Pageof 54
Biochemical Pharmacology|September 29, 2000
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosisB P Neve, J C Fruchart, B Staels
La Revue De Medecine Interne|January 1, 1994
[Vitamin E, antioxidants and atherosclerosis]J M Lecerf, G Luc, J C Fruchart
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 22, 2005
Therapeutical effects of PPAR agonists assessed by biomarker modulationG Chinetti-Gbaguidi, J-C Fruchart, B Staels
The American Journal of Cardiology|April 29, 1998
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus GroupJ C Fruchart, H B Brewer, E Leitersdorf
European Journal of Clinical Investigation|February 18, 1998
Fat ingestion is associated with increased levels of apoC-III- and apoE-B-containing lipoprotein particles in humansJ Dallongeville, E Baugé, P Lebel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 15, 1979
[Lipoprotein electrophoresis on acrylamide-agarose plates, with discontinuous acrylamide gradient]S Moulin, J C Fruchart, P Dewailly, et al.
Biochemical and Biophysical Research Communications|January 15, 1987
Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesR Barbaras, P Puchois, J C Fruchart, et al.
Atherosclerosis|July 1, 1996
Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPARJ Auwerx, K Schoonjans, J C Fruchart, et al.
Diabete & Metabolisme|September 1, 1977
[Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)]J Jaillard, G Sezille, P Dewailly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Lack of triglyceride-lowering properties of fish oil in apolipoprotein e-deficient miceG Asset, E Baugé, J C Fruchart, et al.
Pageof 54